The dynamic roles of advanced glycation end products

Mariyam Khalid, Abdu Adem

Research output: Contribution to journalArticlepeer-review


Advanced glycation end products (AGEs) are a heterogeneous group of potentially harmful molecules that can form as a result of a non-enzymatic reaction between reducing sugars and proteins, lipids, or nucleic acids. The total body pool of AGEs reflects endogenously produced AGEs as well as exogeneous AGEs that come from sources such as diet and the environment. Engagement of AGEs with their cellular receptor, the receptor for advanced glycation end products (RAGE), which is expressed on the surface of various cell types, converts a brief pulse of cellular activation to sustained cellular dysfunction and tissue destruction. The AGEs/RAGE interaction triggers a cascade of intracellular signaling pathways such as mitogen-activated protein kinase/extracellular signal-regulated kinase, phosphoinositide 3-kinases, transforming growth factor beta, c-Jun N-terminal kinases (JNK), and nuclear factor kappa B, which leads to the production of pro-inflammatory cytokines, chemokines, adhesion molecules, and oxidative stress. All these events contribute to the progression of several chronic diseases. This chapter will provide a comprehensive understanding of the dynamic roles of AGEs in health and disease which is crucial to develop interventions that prevent and mitigate the deleterious effects of AGEs accumulation.

Original languageEnglish
JournalVitamins and Hormones
Publication statusAccepted/In press - 2024


  • Advanced glycation end products (AGEs)
  • AGEs-related chronic diseases
  • Diabetic complications
  • Dietary AGEs
  • Inflammatory cytokines
  • NF-κB
  • Oxidative stress
  • RAGE signaling
  • Reactive carbonyl compounds
  • Receptor for AGEs (RAGE)

ASJC Scopus subject areas

  • Physiology
  • Endocrinology


Dive into the research topics of 'The dynamic roles of advanced glycation end products'. Together they form a unique fingerprint.

Cite this